Andreas Wicki, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 1,017,856 shares at $41.01 ($41.3M) on 2022-03-03, disclosed to the SEC on 2022-03-04.
Open-market sale of $41.3M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.24 | 92,501 | $3.7M | 9.0% |
| 2 | $40.24 | 92,501 | $3.7M | 9.0% |
| 3 | $40.52 | 328,927 | $13.3M | 32.3% |
| 4 | $40.52 | 328,927 | $13.3M | 32.3% |
| 5 | $41.01 | 175,000 | $7.2M | 17.4% |
| Total | $40.55 avg | 1,017,856 |
| $41.3M |
| 100% |
| Filing → |
| HRMY | SELL | 2022-11-16 | $6.1M | — | Filing → |
| HRMY | SELL | 2022-11-10 | $15.2M | — | Filing → |
| HRMY | SELL | 2022-11-04 | $68.2M | — | Filing → |